Integrating hypergraph representation learning and gradient-boosted classification for multi-omics glioblastoma gene...

Cancer continues to be a significant worldwide health concern, mostly resulting from modifications in genetic material at the molecular level. The research introduces a hybrid system that integrates raw gene-level multi-omics features with pathway-derived hypergraph embeddings to prioritize glioblastoma genes. The proposed pipeline aggregates gene-level expression, mutation, and copy-number features; constructs a gene-pathway hypergraph from curated pathway memberships; and trains an attention-based hypergraph encoder (HAGNet) to produce structure-aware gene embeddings, evaluated by an XGBoost classifier. We assess the framework using stratified 5-fold cross-validation, reporting ROC-AUC, PR-AUC, Precision@K, and Recall@K at K=50, 100, and 300. Using only raw multi-omics features, the model achieved an ROC-AUC of 0.611 ± 0.020 and a PR-AUC of 0.095 ± 0.017, whereas HAGNet embeddings improved these metrics to 0.768 ± 0.021 and 0.202 ± 0.021, respectively. The integrated model achieved superior overall performance, with ROC-AUC of 0.777 ± 0.021 and PR-AUC of 0.209 ± 0.030, demonstrating that raw omics signals and hypergraph-based structural representations are synergistic. Among the evaluated classifiers, HAGNet + XGBoost achieved the strongest overall discrimination, with ROC-AUC and PR-AUC of 0.7833 ± 0.0102 and 0.2180 ± 0.0122, respectively, outperforming Random Forest, SVM, and Decision Tree. We additionally delineate robustness, ranking, pathway enrichment, and external validation analyses to substantiate biological interpretation. The findings indicate that pathway-aware hypergraph representation learning is a practical and effective enhancement to traditional gene-level features for TCGA-GBM gene prioritization.